[1]
|
DeSantis, C.E., Lin, C.C., Mariotto, A.B., Siegel, R.L., Stein, K.D., Kramer, J.L., et al. (2014) Cancer Treatment and Survivorship Statistics, 2014. CA: A Cancer Journal for Clinicians, 64, 252-271. https://doi.org/10.3322/caac.21235
|
[2]
|
Sutton, E.J., Dashevsky, B.Z., Oh, J.H., Veeraraghavan, H., Apte, A.P., Thakur, S.B., et al. (2016) Breast Cancer Molecular Subtype Classifier That Incorporates MRI Features. Journal of Magnetic Resonance Imaging: JMRI, 44, 122-129. https://doi.org/10.1002/jmri.25119
|
[3]
|
Sardanelli, F., Boetes, C., Borisch, B., Decker, T., Federico, M., Gilbert, F.J., et al. (2010) Magnetic Resonance Imaging of the Breast: Recommendations from the EUSOMA Working Group. European Journal of Cancer (Oxford, England: 1990), 46, 1296-1316. https://doi.org/10.1016/j.ejca.2010.02.015
|
[4]
|
Goldhirsch, A., Wood, W.C., Coates, A.S., Gelber, R.D., Thürlimann, B. and Senn, H.J. (2011) Strategies for Subtypes—Dealing with the Diversity of Breast Cancer: Highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 22, 1736-1747. https://doi.org/10.1093/annonc/mdr304
|
[5]
|
Howlader, N., Cronin, K.A., Kurian, A.W. and Andridge, R. (2018) Differences in Breast Cancer Survival by Molecular Subtypes in the United States. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, 27, 619-626. https://doi.org/10.1158/1055-9965.EPI-17-0627
|
[6]
|
Allarakha, A., Gao, Y., Jiang, H. and Wang, P.J. (2019) Prediction and Prognosis of Biologically Aggressive Breast Cancers by the Combination of DWI/DCE-MRI and Immunohistochemical Tumor Markers. Discovery Medicine, 27, 7-15.
|
[7]
|
Kim, J.Y., Kim, S.H., Kim, Y.J., Kang, B.J., An, Y.Y., Lee, A.W., et al. (2015) Enhancement Parameters on Dynamic Contrast Enhanced Breast MRI: Do They Correlate with Prognostic Factors and Subtypes of Breast Cancers? Magnetic Resonance Imaging, 33, 72-80. https://doi.org/10.1016/j.mri.2014.08.034
|
[8]
|
孙琳琳, 张旭. 乳腺癌磁共振征象与生物学行为、分子分型的关系分析[J]. 生命科学仪器, 2020, 18(5): 35-40.
|
[9]
|
Plaza, M.J., Handa, P. and Esserman, L.E. (2017) Preoperative MRI Evaluation of Axillary Lymph Nodes in Invasive Ductal Carcinoma: Comparison of Luminal A versus Luminal B Subtypes in a Paradigm Using Ki-67 and Receptor Status. AJR American Journal of Roentgenology, 208, 910-915. https://doi.org/10.2214/AJR.15.15788
|
[10]
|
Wu, M. and Ma, J. (2017) Association between Imaging Characteristics and Different Molecular Subtypes of Breast Cancer. Academic Radiology, 24, 426-434. https://doi.org/10.1016/j.acra.2016.11.012
|
[11]
|
Kawashima, H., Miyati, T., Ohno, N., Ohno, M., Inokuchi, M., Ikeda, H., et al. (2017) Differentiation between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Academic Radiology, 24, 1575-1581. https://doi.org/10.1016/j.acra.2017.06.016
|
[12]
|
Martincich, L., Deantoni, V., Bertotto, I., Redana, S., Kubatzki, F., Sarotto, I., et al. (2012) Correlations between Diffusion-Weighted Imaging and Breast Cancer Biomarkers. European Radiology, 22, 1519-1528.
https://doi.org/10.1007/s00330-012-2403-8
|
[13]
|
Yuan, C., Jin, F., Guo, X., Zhao, S., Li, W. and Guo, H. (2019) Correlation Analysis of Breast Cancer DWI Combined with DCE-MRI Imaging Features with Molecular Subtypes and Prognostic Factors. Journal of Medical Systems, 43, 83.
https://doi.org/10.1007/s10916-019-1197-5
|
[14]
|
Jiang, S., Hong, Y.J., Zhang, F. and Li, Y.K. (2017) Computer-Aided Evaluation of the Correlation between MRI Morphology and Immunohistochemical Biomarkers or Molecular Subtypes in Breast Cancer. Scientific Reports, 7, Article No. 13818. https://doi.org/10.1038/s41598-017-14274-3
|
[15]
|
Kumar, P. and Aggarwal, R. (2016) An Overview of Triple-Negative Breast Cancer. Archives of Gynecology and Obstetrics, 293, 247-269. https://doi.org/10.1007/s00404-015-3859-y
|
[16]
|
Boisserie-Lacroix, M., Mac Grogan, G., Debled, M., Ferron, S., Asad-Syed, M., Brouste, V., et al. (2012) Radiological Features of Triple-Negative Breast Cancers (73 Cases). Diagnostic and Interventional Imaging, 93, 183-190.
https://doi.org/10.1016/j.diii.2012.01.006
|
[17]
|
Dogan, B.E. and Turnbull, L.W. (2012) Imaging of Triple-Negative Breast Cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 23, vi23-vi29. https://doi.org/10.1093/annonc/mds191
|
[18]
|
Tian, L., Wang, L., Qin, Y. and Cai, J. (2020) Systematic Review and Meta-Analysis of the Malignant Ultrasound Features of Triple-Negative Breast Cancer. Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine, 39, 2013-2025. https://doi.org/10.1002/jum.15309
|
[19]
|
Uematsu, T. (2011) MR Imaging of Triple-Negative Breast Cancer. Breast Cancer (Tokyo, Japan), 18, 161-164.
https://doi.org/10.1007/s12282-010-0236-3
|
[20]
|
Chen, J.H., Agrawal, G., Feig, B., Baek, H.M., Carpenter, P.M., Mehta, R.S., et al. (2007) Triple-Negative Breast Cancer: MRI Features in 29 Patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 18, 2042-2043. https://doi.org/10.1093/annonc/mdm504
|
[21]
|
Sung, J.S., Jochelson, M.S., Brennan, S., Joo, S., Wen, Y.H., Moskowitz, C., et al. (2013) MR Imaging Features of Triple-Negative Breast Cancers. The Breast Journal, 19, 643-649. https://doi.org/10.1111/tbj.12182
|
[22]
|
Youk, J.H., Son, E.J., Chung, J., Kim, J.A. and Kim, E.K. (2012) Triple-Negative Invasive Breast Cancer on Dynamic Contrast-Enhanced and Diffusion-Weighted MR Imaging: Comparison with Other Breast Cancer Subtypes. European Radiology, 22, 1724-1734. https://doi.org/10.1007/s00330-012-2425-2
|
[23]
|
Moffa, G., Galati, F., Collalunga, E., Rizzo, V., Kripa, E., D’Amati, G., et al. (2020) Can MRI Biomarkers Predict Triple-Negative Breast Cancer? Diagnostics (Basel, Switzerland), 10, 1090.
https://doi.org/10.3390/diagnostics10121090
|
[24]
|
Shang, L.T., Yang, J.F., Lu, J., Wang, T.T., Zhou, Y., Xing, X.B., et al. (2017) Correlations between Apparent Diffusion Coefficient in Diffusion? Weighted Magnetic Resonance Imaging and Molecular Subtypes of Invasive Breast Cancer Masses. Journal of Southern Medical University, 37, 1410-1414.
|
[25]
|
Grimm, L.J., Zhang, J., Baker, J.A., Soo, M.S., Johnson, K.S. and Mazurowski, M.A. (2017) Relationships between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement Is Associated with Luminal B Subtype. The Breast Journal, 23, 579-582.
https://doi.org/10.1111/tbj.12799
|
[26]
|
Michishita, S., Kim, S.J., Shimazu, K., Sota, Y., Naoi, Y., Maruyama, N., et al. (2015) Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy by Magnetic Resonance Imaging in Breast Cancer Patients. Breast (Edinburgh, Scotland), 24, 159-165. https://doi.org/10.1016/j.breast.2015.01.001
|
[27]
|
Ha, R., Jin, B., Mango, V., Friedlander, L., Miloshev, V., Malak, S., et al. (2015) Breast Cancer Molecular Subtype as a Predictor of the Utility of Preoperative MRI. AJR American Journal of Roentgenology, 204, 1354-1360.
https://doi.org/10.2214/AJR.14.13666
|
[28]
|
Nielsen Moody, A., Bull, J., Culpan, A.M., Munyombwe, T., Sharma, N., Whitaker, M., et al. (2017) Preoperative Sentinel Lymph Node Identification, Biopsy and Localisation Using Contrast Enhanced Ultrasound (CEUS) in Patients with Breast Cancer: A Systematic Review and Meta-Analysis. Clinical Radiology, 72, 959-971.
https://doi.org/10.1016/j.crad.2017.06.121
|
[29]
|
Carriero, A., Di Credico, A., Mansour, M. and Bonomo, L. (2002) Maximum Intensity Projection Analysis in Magnetic Resonance of the Breast. Journal of Experimental & Clinical Cancer Research: CR, 21, 77-81.
|
[30]
|
Mori, N., Mugikura, S., Takasawa, C., Miyashita, M., Shimauchi, A., Ota, H., et al. (2016) Peritumoral Apparent Diffusion Coefficients for Prediction of Lymphovascular Invasion in Clinically Node-Negative Invasive Breast Cancer. European Radiology, 26, 331-339. https://doi.org/10.1007/s00330-015-3847-4
|
[31]
|
Cutuli, B., Velten, M. and Martin, C. (2001) Assessment of Axillary Lymph Node Involvement in Small Breast Cancer: Analysis of 893 Cases. Clinical Breast Cancer, 2, 59-65. https://doi.org/10.3816/CBC.2001.n.012
|
[32]
|
Colpaert, C., Vermeulen, P., van Beest, P., Goovaerts, G., Weyler, J., Van Dam, P., et al. (2001) Intratumoral Hypoxia Resulting in the Presence of a Fibrotic Focus Is an Independent Predictor of Early Distant Relapse in Lymph Node-Negative Breast Cancer Patients. Histopathology, 39, 416-425.
https://doi.org/10.1046/j.1365-2559.2001.01238.x
|
[33]
|
Chang, Y.W., Kwon, K.H., Choi, D.L., Lee, D.W., Lee, M.H., Lee, H.K., et al. (2009) Magnetic Resonance Imaging of Breast Cancer and Correlation with Prognostic Factors. Acta Radiologica (Stockholm, Sweden: 1987), 50, 990-998.
https://doi.org/10.3109/02841850903225180
|
[34]
|
Choi, E.J., Youk, J.H., Choi, H. and Song, J.S. (2020) Dynamic Contrast-Enhanced and Diffusion-Weighted MRI of Invasive Breast Cancer for the Prediction of Sentinel Lymph Node Status. Journal of Magnetic Resonance Imaging: JMRI, 51, 615-626. https://doi.org/10.1002/jmri.26865
|
[35]
|
杨丽, 时高峰, 刘辉, 翟英敏, 周涛. 乳腺癌磁共振成像形态学特征与病理的相关性研究[J]. 临床荟萃, 2010, 25(19): 1680-1683.
|